• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促卵泡激素受体变异:继发性闭经的一种罕见病因。

FSH Receptor Variant: An Unusual Cause of Secondary Amenorrhea.

作者信息

Cooper Oluwatosin O, Quint Elisabeth H, Smith Yolanda R, Dendrinos Melina L

机构信息

Academy for Teaching and Learning, Ross University School of Medicine, Miramar, Florida.

Department of Obstetrics & Gynecology, University of Michigan, Ann Arbor, Michigan.

出版信息

J Pediatr Adolesc Gynecol. 2025 Jun 6. doi: 10.1016/j.jpag.2025.06.002.

DOI:10.1016/j.jpag.2025.06.002
PMID:40482956
Abstract

INTRODUCTION

Secondary amenorrhea with high Follicle Stimulating Hormone (FSH) levels and low estradiol is typically diagnosed as primary ovarian insufficiency (POI) in individuals under the age of 40. Low anti-mullerian hormone (AMH) levels support the diagnosis of POI, but normal AMH levels warrant additional evaluation.

CASE PRESENTATION

A 19-year-old female with menarche at age 12 experienced secondary amenorrhea at age 14.5. Initial evaluation showed elevated gonadotropins and low estradiol, which were confirmed on repeat testing. Normal karyotype, no FMR1 repeat expansion, negative autoimmune markers, and normal AMH levels were found. Genetic testing revealed two Follicle Stimulating Hormone Receptor (FSHR) gene variants with high suspicion of pathogenicity.

DISCUSSION

Pathogenic variants in the FSHR gene are an uncommon cause of secondary amenorrhea. Atypical POI cases with a normal AMH level should be evaluated with a genetic consultation.

摘要

引言

在40岁以下的个体中,促卵泡生成素(FSH)水平升高且雌二醇水平降低的继发性闭经通常被诊断为原发性卵巢功能不全(POI)。抗苗勒管激素(AMH)水平降低支持POI的诊断,但AMH水平正常则需要进一步评估。

病例介绍

一名19岁女性,12岁初潮,14.5岁时出现继发性闭经。初步评估显示促性腺激素升高和雌二醇降低,复查结果证实了这一点。核型正常,无FMR1重复扩增,自身免疫标志物阴性,AMH水平正常。基因检测发现两个高度怀疑具有致病性的促卵泡生成素受体(FSHR)基因变异。

讨论

FSHR基因的致病性变异是继发性闭经的罕见原因。AMH水平正常的非典型POI病例应进行遗传咨询评估。

相似文献

1
FSH Receptor Variant: An Unusual Cause of Secondary Amenorrhea.促卵泡激素受体变异:继发性闭经的一种罕见病因。
J Pediatr Adolesc Gynecol. 2025 Jun 6. doi: 10.1016/j.jpag.2025.06.002.
2
A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.一种导致原发性卵巢功能衰竭的新型促卵泡激素受体突变:全外显子组测序在生育方面的应用
Hum Reprod. 2016 Apr;31(4):905-14. doi: 10.1093/humrep/dew025. Epub 2016 Feb 23.
3
Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency孤立性促性腺激素释放激素(GnRH)缺乏症
4
Classic Galactosemia and Clinical Variant Galactosemia经典型半乳糖血症和临床变异型半乳糖血症
5
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
6
Association between novel per- and poly-fluoroalkyl substances and premature ovarian insufficiency: a case-control study.新型全氟和多氟烷基物质与卵巢早衰之间的关联:一项病例对照研究。
Hum Reprod Open. 2025 Jul 12;2025(3):hoaf044. doi: 10.1093/hropen/hoaf044. eCollection 2025.
7
Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.针对卵巢早衰女性的子宫和子宫内膜发育的激素治疗。
Cochrane Database Syst Rev. 2022 Oct 6;10(10):CD008209. doi: 10.1002/14651858.CD008209.pub2.
8
Familial Hypercholesterolemia家族性高胆固醇血症
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
The physiology and clinical utility of anti-Mullerian hormone in women.抗苗勒管激素在女性中的生理学和临床应用。
Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14.

引用本文的文献

1
Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets.成纤维细胞活化蛋白(FAP)作为卵巢纤维化衰老的血清生物标志物:基于转化转录组学靶点的临床验证研究
Int J Mol Sci. 2025 Aug 13;26(16):7807. doi: 10.3390/ijms26167807.